IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc. (IDXX)

Market Closed
8 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
561. 17
-0.99
-0.1761%
$
44.45B Market Cap
55.21 P/E Ratio
- Div Yield
352,224 Volume
9.84 Eps
$ 562.16
Previous Close
Add Transaction
Day Range
555 566.78
Year Range
506.91 769.98
Want to track IDXX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 4 months ago
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings

Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings

Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.

Zacks | 4 months ago
Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?

Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?

IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.

Zacks | 4 months ago
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?

IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?

IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.

Zacks | 5 months ago
3 ESG Stocks to Add to Your Portfolio for Sustainable Returns in 2026

3 ESG Stocks to Add to Your Portfolio for Sustainable Returns in 2026

NVIDIA, IDXX and Microsoft shine on ESG metrics, fueling investor interest with strong returns and ambitious 2030 goals.

Zacks | 5 months ago
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.

Zacks | 5 months ago
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI

3 Medical Instrument Stocks to Counter Industry Woes Using GenAI

VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.

Zacks | 5 months ago
IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?

IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?

IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.

Zacks | 6 months ago
Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue?

Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

Zacks | 6 months ago
Idexx (IDXX) Upgraded to Buy: Here's What You Should Know

Idexx (IDXX) Upgraded to Buy: Here's What You Should Know

Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 6 months ago
What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?

What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?

Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 6 months ago
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 6 months ago
Loading...
Load More